SCHEMBL3226142

SCHEMBL3226142

CCC(C(=O)O)C(=O)C(=O)O.[NaH]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.36
AKR1A1 P14550 1/20 0.36
CHRM3 P20309 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36
DRD3 P35462 1/20 0.36
SLC6A3 Q01959 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CA2 P00918 1/20 0.36
MAPK1 P28482 1/20 0.36
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
SLC1A1 P43005 1/20 0.34
FFAR3 O14843 1/20 0.33
TP53 P04637 1/20 0.32
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3504770 0.97 CHRM1 (0.38) CHRM1AKR1A1CHRM3HTR2AHTR2C
Ethylmalonate SCHEMBL108039 0.82 HDAC1 (0.43) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL247454 0.81 FFAR3 (0.32) TDP1CA2MAPK1FFAR3MEN1
Ethylmalonate SCHEMBL28314706 0.79 HDAC1 (0.41) CHRM1AKR1A1CHRM3HTR2AHTR2C
Ethylmalonate SCHEMBL28315862 0.79 HDAC1 (0.41) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL3831511 0.79 FFAR3 (0.36) TDP1FFAR3ALDH1A1
SCHEMBL117755 0.79 ALDH1A1 (0.39) TDP1MEN1KMT2AALDH1A1
Ethylmalonate SCHEMBL107241 0.78
SCHEMBL5753839 0.78 TDP1 (0.36) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL1300073 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010020432-A8 COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY BIOMARIN IGA LIMITED (BS) 2010-03-11 WO disclosed
WO-2010020432-A2 COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY SUMMIT CORPORATION PLC (GB) 2010-02-25 WO disclosed